Lexicon Pharmaceuticals (NASDAQ:LXRX) Scores Perfect 10 Technical Rating After 119% Rally
16h agoen
From the article
Lexicon Pharmaceuticals (LXRX) shows strong momentum, with 119% yearly gains and perfect technical ratings. The stock passes Minervini's Trend Template with rising moving averages, high relative strength, and explosive 1572% quarterly revenue growth.
Continue reading on ChartMillYou might also wanna read
Wall Street sees more gains ahead for this SpaceX supplier
cnbc.com·9d agoEli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Bars·2d ago
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
Bars·4d ago
Biotech NRx to sell new shares to fund growth and operations
stocktitan.net·1mo ago
Hyperliquid challenges ethereum in trading volume as institutional capital rotates from bitcoin and ether, says FalconX
Hyperliquid (HYPE), a decentralized derivatives exchange, is increasingly competing with ethereum in trading volume as institutional investo
coindesk.com·1mo agoGlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.
GSK·17y ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.